1. Field of the Invention
The present invention relates generally to medical systems and methods for treatment. More particularly, the present invention relates to systems and methods for treating aneurysms.
Aneurysms are enlargements or “bulges” in blood vessels which are often prone to rupture and which therefore present a serious risk to the patient. Aneurysms may occur in any blood vessel but are of particular concern when they occur in the cerebral vasculature or the patient's aorta.
The present invention is particularly concerned with aneurysms occurring in the aorta, particularly those referred to as aortic aneurysms. Abdominal aortic aneurysms (AAA's) are classified based on their location within the aorta as well as their shape and complexity. Aneurysms which are found below the renal arteries are referred to as infrarenal abdominal aortic aneurysms. Suprarenal abdominal aortic aneurysms occur above the renal arteries, while thoracic aortic aneurysms (TAA's) occur in the ascending, transverse, or descending part of the upper aorta.
Infrarenal aneurysms are the most common, representing about eighty percent (80%) of all aortic aneurysms. Suprarenal aneurysms are less common, representing about 20% of the aortic aneurysms. Thoracic aortic aneurysms are the least common and often the most difficult to treat.
The most common form of aneurysm is “fusiform,” where the enlargement extends about the entire aortic circumference. Less commonly, the aneurysms may be characterized by a bulge on one side of the blood vessel attached at a narrow neck. Thoracic aortic aneurysms are often dissecting aneurysms caused by hemorrhagic separation in the aortic wall, usually within the medial layer. The most common treatment for each of these types and forms of aneurysm is open surgical repair. Open surgical repair is quite successful in patients who are otherwise reasonably healthy and free from significant co-morbidities. Such open surgical procedures are problematic, however, since access to the abdominal and thoracic aortas is difficult to obtain and because the aorta must be clamped off, placing significant strain on the patient's heart.
Over the past decade, endoluminal grafts have come into widespread use for the treatment of aortic aneurysm in patients who cannot undergo open surgical procedures. In general, endoluminal repairs access the aneurysm “endoluminally” through either or both iliac arteries in the groin. The grafts, which typically have been fabric or membrane tubes supported and attached by various endoframe structures, are then implanted, typically requiring several pieces or modules to be assembled in situ. Successful endoluminal procedures have a much shorter recovery period than open surgical procedures.
Present endoluminal aortic aneurysm repairs, however, suffer from a number of limitations. For example, a significant number of endoluminal repair patients experience leakage at the proximal juncture (attachment point closest to the heart) within two years of the initial repair procedure. While such leaks can often be fixed by further endoluminal procedures, the need to have such follow-up treatments significantly increases cost and is certainly undesirable for the patient. A less common but more serious problem has been graft migration. In instances where the graft migrates or slips from its intended position, open surgical repair is required. This is a particular problem since the patients receiving the endoluminal grafts are often those who are not considered to be good surgical candidates.
Further shortcomings of the present endoluminal graft systems relate to both deployment and configuration. For example, many of the commercially available endovascular systems are too large (above 12 F) for percutaneous introduction. Moreover, current devices often have an annular support frame that is stiff and difficult to deliver as well as unsuitable for treating many geometrically complex aneurysms, particularly infrarenal aneurysms with little space between the renal arteries and the upper end of the aneurysm, referred to as short-neck or no-neck aneurysms. Aneurysms having torturous geometries are also difficult to treat. Although treatment devices exist for excluding the aneurysms, it can be difficult to visualize the aneurysm, the device, and the flow of blood during deployment to ensure proper sealing and placement of the treatment device.
For these reasons, it would be desirable to provide improved methods and systems for the endoluminal and minimally invasive treatment of aortic aneurysms. In particular, it would be desirable to provide systems having lower delivery profile and methods which can be delivered percutaneously and that can track and be deployed in tortuous vessels. It would also be desirable to provide prostheses with minimal or no endoleaks, which resist migration, which are flexible and relatively easy to deploy, and which can treat many if not all aneurismal configurations, including short-neck and no-neck aneurysms as well as those with highly irregular and asymmetric geometries. Additionally, there is a need for such systems and methods which are compatible with current designs for endoluminal endoframes and grafts, including single lumen endoframes and grafts, bifurcated endoframes and grafts, parallel endoframes and grafts, as well as with double-walled filling structures which are the subject of the commonly owned, copending applications described below. It would also be desirable to provide systems and methods that provide feedback to the operator as to the positioning and deployment of the endoluminal repair device in the aneurysm and allow the operator to visualize the morphology of the aneurysm as well as the flow of blood through the device or aneurysm. The systems and methods would preferably be deployable with the endoframes and grafts at the time the endoframes and grafts are initially placed. At least some of these objectives will be met by the inventions described hereinbelow.
2. Description of the Background Art
U.S. Patent Publication No. 2006/0025853 describes a double-walled filling structure for treating aortic and other aneurysms. Copending, commonly owned U.S. Patent Publication No. 2006/0212112, describes the use of liners and extenders to anchor and seal such double-walled filling structures within the aorta. The full disclosures of both these publications are incorporated herein by reference. PCT Publication No. WO 01/21108 describes expandable implants attached to a central graft for filling aortic aneurysms. See also U.S. Pat. Nos. 5,330,528; 5,534,024; 5,843,160; 6,168,592; 6,190,402; 6,312,462; 6,312,463; U.S. Patent Publications 2002/0045848; 2003/0014075; 2004/0204755; 2005/0004660; and PCT Publication No. WO 02/102282.
The present invention relates generally to medical devices and methods, and more specifically to systems and methods for the treatment of aneurysms, particularly aortic aneurysms including both abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA). The systems may be introduced percutaneously or by surgical cutdown into a patient and may have an outer diameter ranging preferably from 10 French to 18 French and more preferably from 12 French to 16 French.
In a first aspect of the present invention, a system for treating an aneurysm in a blood vessel comprises an elongate flexible shaft having a proximal region and a distal region. The system may include an endograft, such as a filling structure, for excluding the aneurysm and a fenestrated nosecone having a through lumen for both advancement of the shaft along a guidewire and for simultaneously performing angiography. The endograft may comprise a first double-walled filling structure, having an outer and inner wall, the filling structure disposed over the distal region of the shaft. The filling structure may be filled with a hardenable fluid filing medium so that the outer wall conforms to an inside surface of the aneurysm and the inner wall forms a first substantially tubular lumen to provide a path for blood flow. The system also includes a first expandable endoframe or endoframe disposed adjacent the filling structure. The first endoframe is radially expandable within at least a portion of the tubular lumen of the filling structure. In some embodiments, the system includes a second endograft or filling structure having a second endoframe disposed therein, each of the first and second filling structures positioned across the aneurysm. In such an embodiment, the first and filling structures are positioned side-by-side and parallel to one another in at least one plane.
The fenestrated nosecone is attached to the distal region of the inner shaft distal of the endograft. The nosecone has a through lumen, preferably a single through lumen, extending along a longitudinal axis of the nosecone. The nosecone is distally tapered to facilitate advancement of the inner shaft over a guidewire and includes a series of side ports in fluid communication with the through lumen for performing angiography. The system may include contrast media for performing angiography by injecting the contrast media through the guidewire lumen of the inner shaft, which then flows through the through lumen of the nosecone and out the side ports of the nosecone into the vasculature of the patient, preferably while the guidewire is disposed within the lumen. The guidewire lumen of the inner shaft and the lumen of the nosecone may be sized to allow for flow of a contrast media while the guidewire is disposed within the lumen. The through lumen of the nosecone may have a distal narrowed portion sized to slidably receive the guidewire so as to inhibit flow of the contrast media while the guidewire is disposed within, so that the contrast media is directed out through the series of side ports. The series of side ports are preferably pairs of side ports, each side port may be orthogonal to the through lumen. The series of side ports may be arranged in a helical pattern along the longitudinal axis of the nosecone, preferably distributed at regular intervals, such as every 90 degrees, along a helical path of the nosecone.
In many embodiments, the delivery system may include an outer sheath that is disposed at least partially over the filling structure and/or the endoframe. The system may also include a annular knob for retracting the outer sheath over a distal hypotube so as to expose the endograft for deployment at the aneurysm. The distal end of the outer sheath releasably engages with the nosecone at an interface creating a smooth transition between the outer surface of the nosecone and the outer surface of the outer sheath to facilitate advancement of the system through the vasculature. Preferably, the nosecone includes an isodiametric segment or a proximal region of the nosecone having the same outside diameter as the outer sheath, such that when interfaced the isodiametric segment is adjacent the distal end of the outer sheath having the same diameter, thereby creating a smooth transition. The isodiametric segment shifts deflection away from the outer sheath to nosecone interface, thereby maintaining a smooth transition. The interface may also include a radiopaque marker band, such as a gold marker band, on the nosecone and/or the outer sheath.
The system may further comprise an inflation device, such as a syringe, that is fluidly coupled with the filling structure and a pressure monitor. The pressure monitor may also be coupled with the filling structure so as to permit pressure monitoring of the filling structure as the filling structure is filled with the hardenable fluid filling medium. The pressure monitor may comprise a pressure gage, a digital or analog display or the like. The display may monitor a filling pressure in addition to other variables, including but not limited to elapsed time, filling time, and/or curing time. In one embodiment, the gauge includes electronics or a mechanism to filter out pressure spikes during filling. The gauge could include a relief valve to relieve pressure in the event of overfilling. In another embodiment, the pressure apparatus would calculate differential pressure between the inside of the filling structure and the patient's systolic/diastolic pressure in order to facilitate the filling medium process. In one embodiment, the digital display operatively couples near or on the handle so as to allow a physician to monitor pressure or other variables during the procedure. The digital pressure monitor may be battery-powered, detachable and disposable.
In many embodiments, the endoframe or endoframe is comprised of a metal and may be balloon expandable. The endoframe or filling structure may also carry a therapeutic agent that can be released therefrom in a controlled manner. Some therapeutic agents include anti-thrombogenics like heparin or agents which promote endothelial and smooth muscle cell growth, sealing and attachment. The filling structure may comprise a polymer.
The filling structure may also comprise a filling tube that is fluidly coupled therewith and that is adapted to fill the filling structure with the filling medium. The filling tube may also comprise an inner tube that is slidably disposed within an outer filling tube. Both the inner tube and the outer filling tube may be fluidly coupled with the filling structure. The method may comprise filling the filling structure with a fluid filling medium through the inner tube. The method may further comprise removing the inner tube and passing additional fluid filling medium through the filling tube after the inner tube has been removed.
In another aspect of the present invention, a system for treating an aneurysm in a blood vessel comprises an elongate flexible shaft having a proximal region and a distal region. An expandable member is disposed adjacent the distal region and a first expandable endoframe is disposed over the expandable member. The first endoframe is radially expandable from a collapsed configuration to an expanded configuration. A first double-walled filling structure is disposed over the first endoframe. The filling structure has an outer wall and an inner wall and the filling structure is adapted to be filled with a hardenable fluid filing medium so that the outer wall conforms to an inside surface of the aneurysm and the inner wall forms a first substantially tubular lumen to provide a path for blood flow. In the expanded configuration, the first endoframe engages the inner wall of the filling structure. A first releasable coupling mechanism releasably couples the filling structure with the flexible shaft and the coupling mechanism may comprise a tether that is releasably coupled with the filling structure and the flexible shaft. The coupling mechanism constrains axial movement of the filling structure relative to the flexible shaft.
The system includes coupling mechanisms for releasably coupling the filling structure and endoframe to the inner shaft. The coupling mechanisms may include a first and second releasable coupling mechanism. The first releasable coupling mechanism may comprise a first tether which couples the distal end of the endoframe with the inner shaft. In some embodiments, the proximal end of the filling structure may be coupled with the proximal region of the endoframe. In some embodiments, the first tether may comprise a tether loop with a release wire extending therethrough releasably coupling the endoframe to the inner shaft. Preferably, the first tether loop is fixedly attached to the inner shaft and withdrawn with the inner shaft after release of the filling structure and endoframe.
The endoframe may also be coupled with the filling structure. In an exemplary embodiment, the filling structure is coupled to a distal region of the endoframe with four sutures evenly distributed around its distal end. Each suture may be a single thread or strand between the filling structure and endoframe, or may include a suture loop. The suture attachment may include an eyelet coupling the suture loop to the endoframe. Thus, in many embodiments, the filling structure is coupled to the inner shaft through the attached endoframe.
The system may further comprise a second releasable coupling mechanism. The second mechanism may comprise a second tether or tether loop that is releasably coupled with the filling structure and the filling tube and/or inner shaft. The second tether may be attached to the filling structure at the opposite end of the filling structure as the first tether, so as to constrain axial movement of the filling structure relative to the flexible shaft. In many embodiments, the second tether comprises a tether loop attached to the filling tube, the loop extending through a suture on the filling structure and around the release wire, such that so long as the release wire remains within the tether loop the filling structure remains coupled to the filling tube.
The first and second tethers are further coupled to a release wire such that retracting the release wire, after deployment is complete, decouples the first and second tether from the filling structure so that the inner shaft can be removed from the deployed filling structure. The release wire is disposed adjacent the inner shaft and extends through the filling structure and over the endoframe. Once the filling structure and endoframe are deployed, the release wire can be retracted from inside a generally tubular lumen formed by the inner wall of the filling structure to release the filling structure from the inner shaft.
The method may further comprise pre-filling the first filling structure with a pre-filling fluid until the outer wall of the first filling structure conforms to the inside surface of the aneurysm, thereby unfurling the first filling structure. The pre-filling fluid may comprise saline and may be removed from the first filling structure. The method may also comprise pre-filling the first filling structure with pre-filling fluid until the outer wall of the first filling structure conforms to the inside surface of the aneurysm. The method may comprise performing angiography through the side ports of the fenestrated nosecone to detect potential endoleaks, and recording the pressure and filling volume of the first filling medium when endoleaks are no longer observed. The recorded pressure and volume of the pre-filling fluid used to pre-fill the first filling structure may be measured and then the pre-filling fluid may be removed from the first filling structure. Filling the first filling structure with the first fluid filling medium may comprise filling the first filling structure with the first filling medium using substantially the same pressure and volume as measured. The pre-filling fluid may comprise saline or contrast media to assist visualizing the filling process under x-ray fluoroscopy. The first filling medium may be passed through a filling tube that is fluidly coupled with the first filling structure.
Radially expanding the endoframe may comprise inflating a balloon that is disposed on the flexible shaft. Hardening the first fluid filling medium in the first filling structure may comprise polymerizing the first fluid filling medium in situ. In some embodiments, the first fluid filling medium may comprise polyethylene glycol.
A releasable coupling mechanism such as a tether may couple the first filling structure and/or endoframe with the flexible shaft and the step of releasing the first filling structure from the flexible shaft may comprise releasing the coupling mechanism or de-coupling the tether from the first filling structure or endoframe. One end of the tether may be releasably coupled with a release wire and the step of de-coupling the tether may comprise retracting the release wire thereby detaching the tether from the release wire. De-coupling the tether may comprise releasing the tether from a suture loop on the first filling structure. In some embodiments, a second releasable coupling mechanism, such as a tether may couple the first filling structure with the flexible shaft and the step of releasing the first filling structure from the flexible shaft may comprise de-coupling the second tether from the first filling structure. Releasing one or more of the coupling mechanisms may permit separation of a filling tube from the filling structure.
The method may further comprise the step of retracting an outer sheath away from the first filling structure and the first endoframe to allow expansion thereof. Pressure may be monitored during filling of the first filling structure. A filling tube may be released from the first filling structure after the hardenable filling medium has been delivered thereto. Releasing the filling tube may comprise detaching a filling tab coupled with the first filling structure.
In some embodiments, the method may further comprise providing a second elongate flexible shaft having a proximal end, a distal end, and a second expandable member near the distal end. The second flexible shaft may carry a second radially expandable endoframe over the second expandable member and a second double walled filling structure may be disposed over the second endoframe. The second shaft may be advanced in the vasculature of the patient so that the second filling structure is delivered to the aneurysm and the second filling structure is filled with a second fluid filling medium so that an outer wall of the second filling structure conforms to an inside surface of the aneurysm and an inner wall of the second filling structure forms a second substantially tubular lumen to provide a second blood flow path across the aneurysm. The second endoframe is radially expanded from a contracted configuration to an expanded configuration wherein in the expanded configuration the second endoframe engages the inner wall of the second filling structure. The second fluid filling medium may be hardened in the second filling structure and the second flexible shaft is released from the second filling structure. The second shaft may be retracted away from the second filling structure. Positioning, filling and release of the second filling structure generally takes the same form as described above with respect to the first filling structure.
The first filling structure may comprise a filling tube that is fluidly coupled therewith and the step of filling the first filling structure may comprise passing filling medium through the filling tube. The filling tube may comprise an inner tube that is slidably disposed therein and that is also fluidly coupled with the filling structure. The method may further comprise removing the inner tube from the filling tube and supplying additional filling medium to the filling structure by passing the filling medium through the filing tube after the inner tube has been removed therefrom.
These and other embodiments are described in further detail in the following description related to the appended drawing figures.
FIGS. 12 and 13A-13C illustrate an exemplary embodiment and cross-sections of the embodiment.
The present invention relates generally to medical devices and medical methods, and more particularly to endoluminal systems for monitoring and delivering endoluminal treatments, such as endoframes, endografts, and other implantable structures. The systems may be used to monitor the body vessels and blood flow before, during and/or after treatment, and may be used to deploy endoluminal therapies, particularly therapies which involve treating aneurysms. The invention may include improved systems and methods for delivery and deployment of endoluminal therapies in conjunction with angiographic procedures. The invention may further include improved systems and methods for delivery of endografts, such as a filling structure, particularly filling structures having endoframes therein.
Referring now to
The catheter 20 will comprise a guidewire lumen (not shown), a balloon inflation lumen (not shown) or other structure for expanding other expandable components, and a filling tube 26 for delivering a filling medium or material to an internal space 14 of the double-walled filling structure 10. The internal space 14 is defined between an outer wall 16 and inner wall 12 of the filling structure. Upon inflation with the filling material or medium, the outer wall 16 will expand radially outwardly (expanded outer wall 16′ shown in broken line) as will the inner wall 12 (expanded inner wall 12′ shown in broken line). Expansion of the inner wall 12 defines an internal generally tubular lumen 11 through which blood flows after deployment of the filling structure in the aneurysm. The expandable balloon 28 or other structure will be expandable to correspondingly expand the endoframe 18 to provide support and to shape an inner surface of the lumen 11. In this embodiment, the expandable balloon is cylindrically shaped and therefore the generally tubular lumen 11 will also be cylindrically shaped. In other embodiments, the balloon may be pre-shaped to more precisely match the curvature of the vessel. For example, when treating an aortic aneurysm, a tapered, pre-shaped or curved balloon may be used so that the lumen substantially matches the aorta. Various balloon configurations may be used in order to match vessel tortuosity. Pre-shaped, curved or tapered balloons may be used in any of the embodiments disclosed herein in order to obtain a desired lumen shaped.
In a particular and preferred aspect of the present invention, a pair of double-walled filling structures will be used to treat infrarenal abdominal aortic aneurysms, instead of only a single filling structure as illustrated in
In an exemplary method, first, the balloon 116 or 216 is expanded. Expanding the balloon 116 or 216 expands the corresponding filling structure 112 or 212 and endoframe 127, 227 disposed thereon. Next, the expanded filling structure 112 or 212 is filled with the fluid filling medium. Then, the balloon 116 or 216 is deflated to allow a flow of blood through the filling structure 112, 212 filled with the fluid filling medium, while the expanded endoframe 127, 227 maintains the patency of the generally tubular lumen within the expanded filled filling structure 112 or 212. In alternative embodiments, one or both of filling structures 112 or 212 could be filled with the fluid filling medium first, then the balloon 116 or 216 expanded to expand the endoframe 127 or 227 to form a generally tubular lumen in the corresponding filling structure 112 or 212. In still another alternative embodiment, filling structure 112 or 212 could be filled with the fluid filling medium simultaneously with expanding the balloon 116 or 216 disposed therein. Typically, one of the filling structures 112, 212 and associated balloons 116, 216 will be expanded first along with the corresponding endoframe 127, 227, followed by the other filling structure, endoframe and balloon. In some embodiments, both balloons may be radially expanded simultaneously thereby also expanding the filling structures and endoframes simultaneously.
Alternatively, one or both filling structures 112, 212 may be filled with a hardenable material and then the filling structures 112, 212 are radially expanded along with the corresponding endoframe 127, 227. In still other embodiments, combinations of filling and expanding may be performed in different order depending on physician preference and aneurysm anatomy. In some embodiments, an optional pre-filling step may be performed prior to filling with the hardenable filling medium. In this optional step, once the delivery system is positioned across the aneurysm, the filling structure may be filled with CO2 gas, contrast media, saline or other fluids to unfurl the filling structure 10 away from the delivery catheter thereby helping to ensure more uniform filling later on and reduce or eliminate striction between folds of the filling structure that may be present. During unfurling, the filling structure may be partially filled or fully filled so that it conforms to the inner aneurysm wall. Once unfurled, angiography may be performed through a fenestrated nosecone 130 or 230 on the inner catheters shafts 114 or 214 upstream of the aneurysm to detect leaks in the deployed filling structure 10. Once an optimal filling volume and pressure is determined to prevent the occurrence of endoleaks, the fluid may be removed from the filling structure and it may be filled with the hardenable material to expand and conform to the aneurismal space between the lumens and the inner aneurysm wall. Pressure relief valves such as those described herein may also be used to ensure that the filling structure is not over filled. In order to prevent overfilling of the filling structure, any of the pressure relief valves disclosed below may also be used to bleed off excess fluid from the filling structure.
After filling the filling structures 112 and 212 as illustrated in
The double filling structure embodiments preferably will include at least one endoframe deployed within each of the tubular blood flow lumens. The endoframes will generally be endoskeletal structures that lay the foundation for new lumens, and will be deployed within the tubular lumens of the double-walled filling structures using balloon or other expansion catheters (in the case of malleable or balloon-expandable endoframes) and an optional retractable constraining sheath.
Referring now to
In the exemplary embodiment of
Fenestrated Nosecone
To facilitate both advancement of the system and deployment of the filling structure, fenestrated nosecone 30 releasably couples or interfaces with the distal end of outer sheath 40. In an exemplary embodiment, nosecone 30 includes an isodiametric portion 36 which is isodiametric with the outer diameter of the distal end of outer sheath 40 so as to create a smooth transition at the interface and prevent “snowplowing” against a vessel wall as the system advances through the patient's vasculature. Isodiametric portion 36 extends a distance distal of the interface so as to increase the stiffness of the nosecone near the interface and prevent flexure of the nosecone and/or outer sheath at the interface during advancement of the system. Nosecone 30 may also include a portion 37 having an outside diameter slightly smaller than the inside diameter of the distal end of outer sheath 40; thus, portion 37 is disposed within the outer sheath 40 such that the outer sheath 40 fittingly receives portion 37 so as to releasably couple with the nosecone 30. Portion 37 may extend a distance proximal of the interface so as to increase the stability of the coupling and to increase the stiffness near the interface to prevent separation between the nosecone and outer sheath 40 as the system winds through complex or tortuous vasculature, thereby further reinforcing the smooth transition between the nosecone 30 and the outer sheath 40 to reduce the likelihood of “snowplowing” against the vessel wall. The nosecone 30 and/or the outer sheath 40 may further include a radiopaque marker band 31 near the interface to allow a physician to image the location of the distal end of the outer sheath 40 relative to nosecone 30. The resin to manufacture the nosecone may also include a radiopaque filler to facilitate imaging during the procedure.
Nosecone 30 is dimensioned to facilitate advancement in a patient's vasculature. An exemplary nosecone may be between 1 to 4 inches in length, preferably 2.5 to 3 inches, and have an outside diameter tapering from about 0.25 inches at a proximal end to about 0.050 inches at a distal end. The through lumen 32 extending through the nosecone 30 may also reduce in size as the outside diameter tapers down. For example, the through lumen at the proximal end 32B may be between 0.05 and 0.1 inches, preferably about 0.08 inches, and reduce in size gradually or incrementally to 0.02 to 0.04 inches, preferably about 0.05 inches at the distal portion 32A of nosecone 30.
Angiography may be performed by injecting a contrast media through the guidewire lumen of the inner shaft 20, which then flow into the through lumen 32 of nosecone 30 and out the side ports 34, preferably while the guidewire GW is disposed within the guidewire lumen and through lumen 32. Angiography may be performed through nosecone 30 before, during, or after treatment of the aneurysm, and is useful for imaging the flow of blood, particularly for detecting leaks in an endograft deployed in an aneurysm. In an angiography procedure, a radiopaque contrast media is delivered into a blood vessel and an X-ray based imaging technique, such as fluoroscopy, is used to image the flow of the contrast media as it flows through the blood vessel. Preferably, the contrast media is released uniformly into the blood vessel so that the imaging produces a more accurate representation of blood flow through the vessel.
In an exemplary embodiment, fenestrated nosecone 30 includes pairs of side ports 34 arranged in a series equally distributed along the nosecone in a helical fashion so as to evenly distribute the contrast media into the vasculature. Preferably, each of side ports 34 extends in an orthogonal direction from the longitudinal axis of the nosecone 30. In an exemplary embodiment, the nosecone 30 comprises a series of 4 to 10 pairs of side ports 34, preferably 5 to 7 pairs of side ports, arranged in a helical fashion as described above. Typically, a side port 34 has a diameter within a range of 0.01 inches to 0.05 inches, and more preferably within a range of 0.03 to 0.04 inches.
Annular Knob
Carrier knob 50 may include an internal seal 52, such as an silicone O-ring, to prevent fluid outflow from between the distal and proximal segments of the outer sheath 40. Typically, the blood pressure of the patient against internal seal 52 is sufficient to prevent fluid outflow from the body between outer sheath 40 and hypotube 41. As the carrier knob 50 is pulled proximally internal seal 52 slides proximally contacting the outer surface of the hypotube 41 and inside the annular knob 50.
Strain relief element 54 may comprise a tubular element fixedly attached to the distal region of carrier knob 50 and is sized to circumscribe the proximal end of outer sheath 40. The tubular strain relief element 54 may include a plurality of holes 55 which absorb stress and strain from the outer sheath 40 to prevent breakage of the heat bond. Carrier knob 50 may be heat bonded to the outer sheath 40 by covering the proximal end of outer sheath 40 by a laminate material, preferably a polymer material such as Pebax®, placing the tubular element 54 over the laminate covered outer sheath 40, and heating the assembly so that the laminate bonds to the outer shaft 40 and/or the knob 50, preferably bonding with both the outside surface of outer sheath 40 and the inside surface of the tubular strain relief element 54. In an exemplary embodiment, the laminate flows through the holes 55 in the tubular element 54 when heated strengthening the bond between the outer shaft 40 and knob 50. In some embodiments, additional layers of laminate may be placed over the strain relief member 54 during the heat bonding process. The hypotube 41 or main catheter shaft is inserted through the knob 50 from the side opposite the tubular strain relief member and through the proximal end of the outer sheath 40. The system may further include a retaining mechanism to prevent the hypotube 41 from slipping out of the knob 50 when the outer sheath 40 is advanced. The retaining mechanism may comprise a collar, a ring, a pin, or any mechanism suitable to maintain a slidably coupling between the hypotube 41 and the annular knob 50. The system may also include a keying mechanism to prevent rotation between hypotube 41 (main catheter shaft) and sheath 40.
Handle
Pressure Monitoring
In an exemplary method of deploying a filling structure and endoframe, pressure monitoring may be utilized in the following way. After two filling structures have been delivered to the treatment site, both endoframes are radially expanded to help create a lumen for blood flow through the filling structure across the aneurysm. Using data from a patient's computerized tomography (CT) scans, a fill volume of the aneurysm treatment site may be estimated and then divided by two, half for each of the two filling structures. This represents the baseline filling volume for each filling structure and is the minimum volume of filling material to be injected into each of the filling structures. Syringes or other injection devices coupled with a pressure gage may be used to optionally pre-fill each filling structure with contrast material using the baseline volume and the resulting baseline fill pressure may be noted. In addition, the pressure monitoring system may include a pop-off valve to relieve excess pressure in the event of overfilling. The pressure monitoring system may include a sensor inside the filling structure and a sensor monitoring the patient's systolic and or diastolic blood pressure used for calculating the patient's differential blood pressure. A differential blood pressure reading between the filling structure and the patient's systolic and or diastolic pressure simplifies the process of filling the structures as this allows the physician to accurately target the pressure inside the filling structure. This allows unfurling of the filling structure and provides a preliminary assessment of how the expanded filling structures fit into the aneurismal space. Once this is accomplished, the contrast material is removed from the filling structures (in a method utilizing a pre-filling step). Again using the patient CT data, a functional fill volume may be determined. This volume is a percentage of the aneurysm volume obtained from the CT data, or it may be a predetermined number and is the volume of filling material that effectively seals and excludes the aneurysm. Functional fill pressure will be the pressure at which the functional fill volume is attained. A polymer fill dispenser may then be used to fill each filling structure with the functional fill volume and the functional fill pressure is noted. While holding the functional fill volume and pressure, the filling structure may be observed under fluoroscopy to check for proper positioning, filling and the absence of leakage across the aneurysm. If leaks are observed, additional polymer may be added to the filling structures until the leaks are prevented or minimized. Excessive additional polymer should not be added to the filling structure in order to avoid exceeding a safe fill volume or safe fill pressure. Once the physician is satisfied with the filling and positioning of the filling structures, stopcocks to the filling structures may be closed to allow the polymer to harden and then the delivery devices may be removed from the patient.
The methods may also include use of a pressure monitoring system that allows a physician to monitor the pressure before, during or after filling the filling structure. The system may include a user interface for displaying the pressure output and may optionally include a time output displayed in conjunction with the pressure output. The monitoring system may also include a processor for analyzing the pressure data. The processor may be programmed to normalize the pressure data. The pressure monitoring system enables the physician to closely monitor the filling pressure during deployment of the filling structure and may include additional functions to facilitate proper deployment, including: pressure cut-off switches, warning indicators if the measured filling pressure is outside an acceptable range, and pressure bleed off switches to optimize filling pressure and compensate for fluctuations in pressure during filling. The monitoring system may also record the pressure data during deployment. Additionally, in embodiments deploying two filling structures, the monitoring systems may be operatively coupled such that the system or a physician may monitor pressures during filling of one filling structure in response to pressure output readings from the other adjacent filling structures.
Pressure monitoring can also be performed at various stages of the aneurysm repair procedure to help control the filling process of the filling structure. The monitoring of pressures serves to reduce the risk of dissection, rupture or damage to the aneurysm from over-pressurization and also can be used to determine an endpoint for filling. Monitoring can be done before, during or after filling and hardening of the filling structure with filling medium. Specific pressures which can be monitored include the pressure within the internal space of the filling structure as well as the pressure in the space between the external walls of the filling structure and the inner wall of the aneurysm. A composite measurement can also be made combining pressures such as those measured within the interior space of the filling structure, together with that in the space between the external walls of the structure and the aneurysm wall or other space at the aneurysm site and an external delivery pressure used by a fluid delivery device, such as a pump or syringe, to deliver the filling medium. Control decisions can be made using any one of these pressure measurements or a combination thereof. Methods of pressure monitoring are discussed in detail in related commonly-owned applications: U.S. patent application Ser. No. 11/482,503 and U.S. patent application Ser. No. 12/429,474, the entire contents of which are incorporated herein by reference.
Delivery System Coupling Mechanisms
Tether 42 may comprise a tether loop fixedly attached to inner shaft 20 distal of the filling structure 10, the tether loop extending through an opening in endoframe 18 and around release wire 46, as shown in detail in
Tether 44 may comprise a tether loop fixedly attached to filling tube 26, which then extends through a suture loop 45 on the proximal end of filling structure 10 and around the release wire 46. So long as release wire 46 remains within the suture loop 45, filling tube 26 remains coupled with the proximal end of filling structure 10. Tether 44 may inhibit movement of the proximal region of the filling structure 10 during delivery, and may help prevent release of the fill tube 26 from the filing structure 10. Thus, tether 44 provides a fail safe mechanism prior to filling and during filling or re-filling of the filling structure, until the procedure is over, at which time the release wire can be retracted releasing the coupling between filling tube 26 and the filling structure 10.
Once the filling structure 10 has been deployed and filled with hardenable fluid filling medium, the release wire 46 can be withdrawn by pulling the proximal end of the release wire 46 from the handle 60. After releasing the filing structure 10 and endoframe 18, the delivery system can be withdrawn from the body as tether loops 42 and 44 no longer couple the filling structure 10 or endoframe 18 to the system. In an exemplary embodiment, the release wire 46 extends the length of and runs parallel to inner shaft 20. During delivery, the distal end of release wire 46 is releasably coupled to inner shaft 20 just proximal of the nosecone 30, as shown in detail in
As shown in
In an exemplary embodiment, suture 47 comprises a single thread having one end attached to endoframe 18 and the other end attached to endoframe 18, as shown in
While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. The various features of the embodiments disclosed herein may be combined or substituted with one another. Therefore, the above description should not be taken as limiting in scope of the invention which is defined by the appended claims.
The present application is a non-provisional of, and claims the benefit of U.S. Provisional Patent Application No. 61/434,290, filed Jan. 19, 2011, the entire contents of which are incorporated herein by reference. The present application is related to U.S. patent application Ser. No. 12/429,474, filed on Apr. 24, 2009, the full disclosure of which is incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
61434290 | Jan 2011 | US |